Identification of high affinity drug-target interactions (DTI) is a major research question in drug discovery. In this study, we propose a novel methodology to predict drug-target binding affinity using only ligand SMILES information. We represent proteins using the word-embeddings of the SMILES representations of their strong binding ligands. Each SMILES is represented in the form of a set of chemical words and a protein is described by the set of chemical words with the highest Term Frequency-Inverse Document Frequency (TF-IDF) value. We then utilize the Support Vector Regression (SVR) algorithm to predict protein -drug binding affinities in the Davis and KIBA Kinase datasets. We also compared the performance of SMILES representation with the recently proposed DeepSMILES representation and found that using DeepSMILES yields better performance in the prediction task. Using only SMILESVec, which is a strictly string based representation of the proteins based on their interacting ligands, we were able to predict drug-target binding affinity as well as or better than the KronRLS or SimBoost models that utilize protein sequence.
Introduction
Identification of high affinity drug-target interactions is an important first step in the drug discovery pipeline. The development of novel drugs is an expensive and resource-consuming process and the repurposing/repositioning of existing approved drugs is a major alternative.
1 Therefore, exploiting the available protein -drug interaction knowledge can provide a good starting point in drug repurposing studies. Furthermore, understanding bimolecular recognition between proteins and drugs can also provide valuable information for generation of novel drugs using generative models.
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Drug-target interaction (DTI) prediction has often been investigated as a binary classification problem, [5] [6] [7] [8] [9] [10] [11] but recent studies have also been focusing on the prediction of the strength of the interaction between the drug and its target. [12] [13] [14] Binding affinity is often available data is limited, and (iv) the prediction algorithm needs to take the level of noise in experimental measurements into account. As the number and reproducibility of the available protein -ligand interaction data increases, utilizing this large data set provides access to a larger chemical space, and a reduction in signal to noise ratio.
Recent studies employed deep learning architectures such as Convolutional Neural Networks (CNNs) to predict binding affinity 2, 16, 17 utilizing 3D-based information of drug-target complex to address point (i). The major drawback of these approaches is that the available information on 3D structure of the protein -compound complex is limited compared to the sequence information of proteins and compounds as stated in point (ii). Therefore, a sequence based approach can take advantage of the increasing wealth of information on pro-tein -drug recognition. String based approaches take advantage of the tools and algorithms developed in the natural language processing (NLP) domain. and even in proposing novel scaffolds by expanding the chemical space.
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In a recent study, our team proposed a CNN-based model to represent proteins based on their sequence information and their interacting compounds using Simplified Molecular
Input Line Entry System (SMILES) form.
14 The high-level representations were then fed into a feed-forward neural network to predict drug-target binding affinity with a promising performance. In this work, we observed that the protein sequences were hard to model even when the powerful CNN architecture was used. Protein sequences contain binding regions (residues) but these constitute a small fraction of the total sequence. Therefore, the noise to signal ratio is higher for protein sequences, leading to lower performance. Furthermore, the residues that participate in binding are usually not placed consecutively in the sequence due to the folded nature of the protein, complicating the task to distinguish the patterns that are active in binding.
In this study, we provide an alternative approach to represent proteins by their interacting ligands instead of using their sequences. The chemical similarity of the interacting ligands has been used to detect biologically and functionally similar proteins in many studies. [24] [25] [26] [27] Our team has recently shown that ligand-based protein representation produced either comparable or better performance than sequence based representations in a protein clustering task. 27 Ligands were represented utilizing their SMILES forms, which were subsequently converted into high-dimensional vectors by the Word2Vec algorithm. 28 We 
Ligand representation
In this study, we adopted a recent approach, SMILESVec, to describe chemical entities based on their SMILES representations. 27 SMILESVec utilizes the Word2Vec algorithm to learn high-dimensional embeddings for the chemical words that are extracted from SMILES strings as 8-character long overlapping substrings. Word2Vec is a type of neural-network that learns high-dimensional representations of words by training on a large text corpus.
28
The model is successful at capturing the semantic similarity between words that appear in similar contexts, since it considers the neighboring words of each word within a window frame during training. 
SMILESVec is described as in Equation 2
, in which n is equal to the number of chemical words (cw) extracted from the SMILES string of a compound and vector(cw k ) represents the embedding of the k th chemical word. 27 Finally, the compound is described as the average of the vectors of the chemical words in its SMILES representation.
To train the Word2Vec algorithm, approximately 2M canonical SMILES strings from Pubchem database were used. We used the Gensim implementation 35 of Word2Vec with the skip-gram approach and the size of the vectors was set to the default value of 100. Figure 2 illustrates the process of how the embeddings of the chemical words are created.
We also utilized a recent approach named DeepSMILES, that proposes a new syntax for the representation of SMILES strings. 31 DeepSMILES hypothesizes that the proposed syntax will improve the performance of machine learning models that deal with SMILES strings with the help of the modifications on the branch and ring representations in the SMILES.
Therefore, in order to investigate the effectiveness of the DeepSMILES syntax, we first converted our training data of 2M canonical SMILES into DeepSMILES. Then, we created 8-charactered sub-sequences from each DeepSMILES to train the Word2Vec algorithm. The ligand vector was created using Equation 2. We will refer to DeepSMILES-based embeddings as DeepSMILES-Vec throughout the article.
Protein representation
In order to represent proteins, we adopted a ligand-centric approach, where a protein is 
where T F refers to the number of occurrences of cw in that set of chemical words. IDF weight, on the other hand, assigns higher importance to the rare words in a corpus. It is described as in Equation 4 :
where cw, S and N denote the chemical word, SMILES corpus, and number of SMILES in the corpus, respectively. 30 To compute the IDF weights of the chemical words, we used the same SMILES corpus (∼ 2M compounds from Pubchem) that we used to train the ). In this study K is set as 100.
We also followed two strategies to choose the set of ligands used to represent a protein:
i) using all interacting ligands and ii) using the ligands with strong binding affinity values. 
We also applied the TF-IDF weighting approach to select the top K sub-sequences with the higher TF-IDF weights to represent proteins in which the number of unique sub-sequences are represented with J (Equation 7). K is chosen as 100 in this study.
We collected 550K protein sequences from the UniProt database to train a Word2Vec model and to learn representations for protein sub-sequences.
Protein-ligand representation
Proteins and ligands are both described with 100-dimensional real-valued word embeddings.
Therefore, the input for the prediction model is a 200-dimensional vector, which is equal to the concatenation of the protein and ligand vectors for each protein-ligand pair.
Support Vector Regression (SVR)
Support Vector Machine (SVM) is a supervised learning model that allows mapping nonlinear data to the linear space with the use of kernel functions. 36 Kernel function usage is one of the major factors that makes SVM popular among the researchers. SVMs have two main categories: Support Vector Classification (SVC) and Support Vector Regression (SVR). SVR is a popular model among machine learning methodologies and has been successfully applied to the bioactivity prediction task in the past. 37 For the cases where the data is linearly separable, our model is y(x) = w T x + w 0 and we aim to minimize the following function:
For the cases where data is not linearly separable, then slack variables γ are introduced as the penalty of misclassification. We also use a penalty factor C and the problem becomes:
basis function kernel.
Evaluation
The performance of the proposed model was measured by calculating the Concordance Index (CI) and Mean Squared Error (MSE) metrics. CI evaluates the performance of a model that outputs continuous values,:
where b x is the prediction value for the larger affinity δ x , b y is the prediction value for the smaller affinity δ y , Z is a normalization constant, h(m) is the step function:
MSE estimates the difference between the predicted values (p) and the vector of actual values (y)
. n indicates the number of samples.
Results and discussion
With this study, we introduce a novel drug -target binding affinity prediction method based only on SMILES string representation with which ligands and their target proteins are represented. We adopted the Support Vector Regression (SVR) algorithm as the prediction algorithm and performed our experiments on the Davis and KIBA Kinase datasets.
Baseline: Protein sequence based methodologies
We compared the methods presented here with two studies that employ traditional machine learning learning models. These state of the art models were used as our baseline.
The first study uses Kronecker-Regularized Least Squares (KronRLS) algorithm to predict binding affinity in which both proteins and compounds are represented with their pairwise similarity score matrices. 12 In order to compute similarity between proteins and between compounds, Smith-Waterman (S-W) algorithm and PubChem structure clustering tool (http://pubchem.ncbi.nlm.nih.gov) were utilized, respectively. In the second study, a gradient boosting machine based method, namely SimBoost, is employed for the prediction of the binding affinity. 13 The presented approach depends on feature engineering of compounds and proteins utilizing information such as similarity and network-inferred statistics.
Experiment Settings
We evaluated the performance of the presented models on the benchmark datasets Davis
32
and KIBA 33 and used the same training and test folds that were used in our previous work
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(https://github.com/hkmztrk/DeepDTA). In these folds, both datasets were randomly divided into six equal parts and one part was separated as the independent test set. The remaining parts of the data set were used to determine the hyper-parameters C and γ via five-fold cross validation. We chose the values for C and γ among 0.01, 1.0, 100.0 and 0.1, 1.0, 10.0, respectively. The parameter combination with which we obtained the best CI value on the training set was selected to model the test set. We performed statistical significance tests with paired t-test with the 95% confidence interval.
Results
In this study, we propose a model to predict the binding affinity of drug-targets using only We observe that even though limited number of protein sub-sequences were used, using the top-K sub-sequences with high TF-IDF weights (Model (2)) yielded better results than plain ProtVec (Model (1)) in terms of both CI and MSE (Table 1 Public databases such as ChEMBL 41 and PubChem 42 provide the affinity value for a given experiment. Not surprisingly, the use of strong-binding ligands to describe proteins led to a
higher performance than using all tested ligands. Comparing the performance of Model (4) with state-of-art models in the task of drug-target binding affinity prediction on Davis set, we observe that even with a strictly SMILES-based approach, Model (4) provides comparable CI value and better MSE performance (0.871, 0.232) to KronRLS (0.871, 0.379) 12 and SimBoost (0.872, 0.282) 13 approaches both of which utilize sequence information of proteins. In conclusion, even without the use of protein sequence, we were able to define proteins with the important chemical words that are extracted from their ligands. The use of TF-IDF weighting to identify the significant chemical words proved to be a useful approach compared to the model in which all chemical words were used. We also observed an improvement in the models when DeepSMILES syntax was used instead of regular SMILES syntax. We hypothesize that when also combined with the DeepSMILES-based compound representation, prediction performance of the proposed model (5) could improve.
Chemical words
In this study, we used two different SMILES syntax to describe the compounds which in turn were utilized to build representations for their interacting proteins. DeepSMILES is proposed recently in order to transform regular SMILES into a more machine-learning friendly syntax.
The use of single ring closure and the utilization of 'close parenthesis' instead of paired parantheses are the major novel features of DeepSMILES syntax.
As a case study, we selected ALK tyrosine Kinase (UniProt ID:Q9UM73) and inspected We then investigated the top-five chemical words with highest TF-IDF values that were extracted from DeepSMILES-Vec based representation, which were 'CC=C6N%2', '13%20)))', '3%20))))', 'C%13%20)', '%13%20))' . We observed that all of these chemical words are present in only three ligands with PubChem identifiers 126565, 51004351 and 44259. We should note that these three ligands were also identified using SMILES but the chemical words and their corresponding weights were eventually different.
We also analyzed the KIBA dataset in terms of chemical words that are created from 
Conclusion
With this study, we proposed a novel approach to predict drug-target binding affinity by We were able to predict drug-target binding affinity using only SMILES strings without using any protein sequence or structure information. As expected, using only the high affinity ligands in the protein representation provides a significantly better performance than using all available or tested ligands. Furthermore, the use of TF-IDF weights to determine the most informative protein sub-sequences in protein representation provided significant improvement for the prediction task. We also showed that a recently introduced syntax for SMILES, DeepSMILES, provides better performance than regular SMILES.
The power of the ligand based representation lies in its ability to describe functional properties of a protein. A limitation of our approach is that it is only available for datasets that have proteins with at least one ligand interaction. On the other hand, structure based prediction tools are limited by the small number of protein -drug complex structures. Our results suggest that adding our ligand centric approach to approaches that utilize orthogonal pieces of information such as 3D structure of the complex, or binding site residues on the protein can provide significant depth to our understanding of the mechanism of proteindrug recognition.
